{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:35:28Z","timestamp":1792640128720,"version":"4.5.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI084024"],"award-info":[{"award-number":["AI084024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Anaerobic organisms are important pathogens in acute pelvic inflammatory disease (PID). The currently recommended PID regimen of a single dose of ceftriaxone and doxycycline for 14 days has limited anaerobic activity. The need for broader anaerobic coverage is unknown and concerns have been raised about metronidazole tolerability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a randomized, double-blind, placebo-controlled trial comparing ceftriaxone 250 mg intramuscular single dose and doxycycline for 14 days, with or without 14 days of metronidazole in women with acute PID. The primary outcome was clinical improvement at 3 days following enrollment. Additional outcomes at 30 days following treatment were the presence of anaerobic organisms in the endometrium, clinical cure (absence of fever and reduction in tenderness), adherence, and tolerability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We enrolled 233 women (116 to metronidazole and 117 to placebo). Clinical improvement at 3 days was similar between the 2 groups. At 30 days following treatment, anaerobic organisms were less frequently recovered from the endometrium in women treated with metronidazole than placebo (8% vs 21%, P &amp;lt; .05) and cervical Mycoplasma genitalium was reduced (4% vs 14%, P &amp;lt; .05). Pelvic tenderness was also less common among women receiving metronidazole (9% vs 20%, P &amp;lt; .05). Adverse events and adherence were similar in each treatment group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In women treated for acute PID, the addition of metronidazole to ceftriaxone and doxycycline was well tolerated and resulted in reduced endometrial anaerobes, decreased M. genitalium, and reduced pelvic tenderness compared to ceftriaxone and doxycycline. Metronidazole should be routinely added to ceftriaxone and doxycycline for the treatment of women with acute PID.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Trials Registration<\/jats:title>\n                  <jats:p>NCT01160640.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciaa101","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T20:09:42Z","timestamp":1580501382000},"page":"1181-1189","source":"Crossref","is-referenced-by-count":79,"title":["A Randomized Controlled Trial of Ceftriaxone and Doxycycline, With or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease"],"prefix":"10.1093","volume":"72","author":[{"given":"Harold C","family":"Wiesenfeld","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"},{"name":"Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A","family":"Meyn","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"},{"name":"Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Darville","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid S","family":"Macio","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L","family":"Hillier","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"},{"name":"Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"2021040811223864700_CIT0001","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/infdis\/jix198","article-title":"Mycoplasma genitalium in women: current knowledge and research priorities for this recently emerged pathogen","volume":"216","author":"Wiesenfeld","year":"2017","journal-title":"J Infect Dis"},{"key":"2021040811223864700_CIT0002","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9378(96)70158-8","article-title":"Role of bacterial vaginosis-associated microorganisms in endometritis","volume":"175","author":"Hillier","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"2021040811223864700_CIT0003","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/423963","article-title":"Bacterial vaginosis and anaerobic bacteria are associated with endometritis","volume":"39","author":"Haggerty","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2021040811223864700_CIT0004","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/sextrans-2015-052285","article-title":"Identification of novel microbes associated with pelvic inflammatory disease and infertility","volume":"92","author":"Haggerty","year":"2016","journal-title":"Sex Transm Infect"},{"key":"2021040811223864700_CIT0005","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64(RR-03)","author":"Centers for Disease Control and Prevention","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"2021040811223864700_CIT0006","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0956462417744099","article-title":"2017 European guideline for the management of pelvic inflammatory disease","volume":"29","author":"Ross","year":"2018","journal-title":"Int J STD AIDS"},{"key":"2021040811223864700_CIT0007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/sextrans-2018-053693","article-title":"Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials","volume":"95","author":"Savaris","year":"2019","journal-title":"Sex Transm Infect"},{"key":"2021040811223864700_CIT0008","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00007435-197710000-00001","article-title":"Acute pelvic inflammatory disease: characteristics of patients with gonococcal and nongonococcal infection and evaluation of their response to treatment with aqueous procaine penicillin G and spectinomycin hydrochloride","volume":"4","author":"McCormack","year":"1977","journal-title":"Sex Transm Dis"},{"key":"2021040811223864700_CIT0009","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/0002-9378(91)91479-G","article-title":"A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis","volume":"164","author":"Wendel","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"2021040811223864700_CIT0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/JCM.29.2.297-301.1991","article-title":"Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation","volume":"29","author":"Nugent","year":"1991","journal-title":"J Clin Microbiol"},{"key":"2021040811223864700_CIT0011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.anaerobe.2019.02.005","article-title":"Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents","volume":"56","author":"Petrina","year":"2019","journal-title":"Anaerobe"},{"key":"2021040811223864700_CIT0012","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0002-9378(16)33026-5","article-title":"A comparison of clindamycin-gentamicin and penicillin-gentamicin in the treatment of post-cesarean section endomyometritis","volume":"134","author":"diZerega","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"2021040811223864700_CIT0013","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/infdis\/jix132","article-title":"New horizons in Mycoplasma genitalium Treatment","volume":"216","author":"Bradshaw","year":"2017","journal-title":"J Infect Dis"},{"key":"2021040811223864700_CIT0014","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/OLQ.0000000000000924","article-title":"Clinical features and therapeutic response in women meeting criteria for presumptive treatment for pelvic inflammatory disease associated with Mycoplasma genitalium","volume":"46","author":"Latimer","year":"2019","journal-title":"Sex Transm Dis"},{"key":"2021040811223864700_CIT0015","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/JCM.01384-08","article-title":"Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR","volume":"47","author":"Fredricks","year":"2009","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa101\/33136645\/ciaa101.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/7\/1181\/36985662\/ciaa101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/7\/1181\/36985662\/ciaa101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T11:22:58Z","timestamp":1617880978000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/72\/7\/1181\/5735325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,2,13]]},"published-print":{"date-parts":[[2021,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa101","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,2,13]]}}}